Drug Profile
Research programme: glucan-based wound therapeutics - TR Therapeutics
Alternative Names: Glucocol; JSD-114Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Glycotex; TR Therapeutics
- Class Glucans
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Wounds
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Wounds in USA
- 09 Sep 2005 Preclinical trials in Wounds in USA (unspecified route)